Article
Robust CRISPR/dCas13 RNA blockers specifically perturb miRNA-target interactions and…
medRxiv · 2024 · Hanifi, M.; Ates-Kalkan, P. S.; Wen, W. X.; Fischer, M.; Kroesen, A.; Yu, Z.; Wood, M.; Thongjuea, S.; Mead, A.; Fulga, T. A.; Rinaldi, C.; Sauka-Spengler, T.
Key facts
| Title | Robust CRISPR/dCas13 RNA blockers specifically perturb miRNA-target interactions and rescue type 1 myotonic dystrophy pathology |
|---|---|
| First author | Hanifi, M.; Ates-Kalkan, P. S.; Wen, W. X.; Fischer, M.; Kroesen, A.; Yu, Z.; Wood, M.; Thongjuea, S.; Mead, A.; Fulga, T. A.; Rinaldi, C.; Sauka-Spengler, T. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.09.16.612263 |
| Devices mentioned | BK110039, DEN000008, K022086 |
| Product codes mentioned | HXK, JCI, JJH, KIP, KIT, MVU, NDS, NJT, PFF, PFT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1